Ginkgo Bioworks Holdings, Inc. has grown revenue −30% a year over three years and −3.4% a year over five. Revenue growth, 3-year annual rate: −30% (Biotechnology median +17%). Revenue growth, 5-year rate: −3.4%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

DNAGinkgo Bioworks Holdings, Inc.

Healthcare

$11.34-23% 1Y

$11.34

$5.4852 weeks$16.09

Is it growing?

Watch

Growth is fading: revenue shrinking (−47% year on year) and operating margin narrowing (−110.5 points).

2 to watch, 1 without data

Revenue trend−47% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−110.5 points operating

Trailing-twelve-month operating margin, -275.2% now against -164.7% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is DNA growing?

Ginkgo Bioworks Holdings, Inc. has grown revenue −30% a year over three years and −3.4% a year over five.

−30%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −3.4%
Revenue growth, 5-year rate · −30% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›